AN ACT relating to prescription drugs.

Amend KRS 304.17A-164 to define and redefine terms; establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with prescription drug cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225,…

Introduced: January 28, 2026

Last action: February 4, 2026

To Banking & Insurance (H)

Read the full text Kentucky Legislature LegiScan

AI-generated — always verify with primary sources

Plain-language summary

Beta

This bill sets rules for how health insurance plans handle the costs of prescription drugs, including requiring that savings from drug manufacturer rebates be passed along to patients at the pharmacy counter. It also applies these rules to state employee health plans, certain college and university health plans, and other limited health benefit plans. The changes would take effect for health plans issued or renewed starting January 1, 2027. Who it may affect: Kentuckians with health insurance who use prescription drugs, state employees, and students or employees covered by health plans at public colleges and universities.

Open official bill text (PDF)·Report a problem with the summary